Archives

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2019 on February 7 prior to the opening of trading on the New York Stock Exchange. The company...

DUBLIN, Ohio, January 8, 2019 — Cardinal Health, Inc. announced today it has acquired Mirixa Corporation, a leading provider of technology-enabled solutions for the provision of medication...

As part of its long-standing commitment to reduce opioid misuse and abuse, the Cardinal Health Foundation is pleased to announce a $530,000 grant to the Ohio Hospital Association (OHA) to identify...

Cardinal Health (NYSE: CAH) today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit...

Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty...

DUBLIN, Ohio, November 28, 2018 — Cordis, a Cardinal Health company (NYSE: CAH), today announced that the U.S. Food and Drug Administration (FDA) has approved its INCRAFT® AAA Stent Graft...

Cardinal Health inventory management solutions (also known as WaveMark™) has introduced a supply chain automation solution designed for the unique challenges hospitals face in operating rooms...

At the 2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting, Cardinal Health will highlight a comprehensive approach that addresses the top concern of hospital and...

Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2019 revenues of $35.2 billion, an increase of 8 percent. The company also reported growth in GAAP operating earnings of 211...

Cordis, a Cardinal Health company, today announced the U.S. launch of MYNX CONTROL™ Vascular Closure Device (VCD). MYNX CONTROL™ VCD integrates active...